• Publications
  • Influence
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study
1Department of Genomic Medicine, Institute of Human Development, Manchester Academic Health Science Centre (MAHSC), Central Manchester University Hospitals NHS Foundation Trust, Manchester, UKExpand
  • 51
  • 3
  • PDF
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic
Background:Randomised trials of tamoxifen versus placebo indicate that tamoxifen reduces breast cancer risk by approximately 33%, yet uptake is low. Approximately 10% of women in our clinic enteredExpand
  • 54
  • 2
Breast cancer risk feedback to women in the UK NHS breast screening population
Introduction:There are widespread moves to develop risk-stratified approaches to population-based breast screening. The public needs to favour receiving breast cancer risk information, which ideallyExpand
  • 30
  • 2
Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme
Accurate individualized breast cancer risk assessment is essential to provide risk–benefit analysis prior to initiating interventions designed to lower breast cancer risk and start surveillance. WeExpand
  • 12
  • 1
Breast Cancer Risk in Young Women in the National Breast Screening Programme: Implications for Applying NICE Guidelines for Additional Screening and Chemoprevention
In the United Kingdom, women at moderate and high risk of breast cancer between the ages of 40 and 49 years are eligible for annual mammographic screening and preventive therapy with tamoxifen. Here,Expand
  • 25
  • 1
  • PDF
EMBASE search filter
MEDLINE search filter
PROCAS two-page questionnaire